Australia launches three-year plan to tackle cancer

27 August 2011

Cancer Australia has released its Strategic Plan 2011-2014, to provide leadership and direction at a time of increasing cancer incidence. The Strategic Plan, which launched by the Nicola Roxon, Minister for Health and Ageing on August 26, will focus on fostering collaboration and engagement across the health system, building the knowledge base in cancer and seeking to shape the effectiveness of cancer control programs at a national level.

Helen Zorbas, chief executive of Cancer Australia, said the Strategic Plan identifies key issues and strategies to improve cancer control. “Cancer Australia will provide consumers, clinicians, researchers and educators with access to trusted and up-to-date information to guide clinical best practice and inform consumer decision making,” Dr Zorbas said, adding: Central to our efforts is the use of evidence to advance improvements across the cancer continuum and the use of innovative approaches to deliver best practice care and support.”

Focus on less common cancers

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical